Filing Details
- Accession Number:
- 0001209191-20-050028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-10 18:05:53
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-10 18:05:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1589597 | Edward Troy Wilson | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-08 | 50,000 | $26.00 | 306,736 | No | 4 | S | Indirect | by Araxes Pharma LLC |
Common Stock | Disposition | 2020-09-10 | 1,025 | $28.00 | 305,711 | No | 4 | S | Indirect | by Araxes Pharma LLC |
Common Stock | Acquisiton | 2020-09-10 | 37,030 | $6.15 | 65,126 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-10 | 37,030 | $28.00 | 28,096 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | by Araxes Pharma LLC |
No | 4 | S | Indirect | by Araxes Pharma LLC |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase common stock | Disposition | 2020-09-10 | 37,030 | $0.00 | 37,030 | $6.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
174,947 | 2027-01-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,795,017 | Indirect | by Red Fish Blue Fish Revocable Trust |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020.
- The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020.
- This option vests in 48 equal monthly installments commencing on January 23, 2017.